Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its own once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) growth of...

Daiichi pays Merck $170M to create bronchi cancer T-cell engager pact

.Merck &amp Co. has actually rapidly redeemed a number of the prices of its own Spear Therapies purc...

BioMarin standstills preclinical gene treatment for heart disease

.After BioMarin administered a springtime tidy of its own pipe in April, the provider has actually c...

Eisai plants molecular adhesive SEED with $1.5 B biobucks deal

.Significant Pharmas continue to be stuck to the concept of molecular adhesive degraders. The latest...

Life science credit scores firm unveils with $600M

.A brand new international lifestyle scientific research debt company, called Symbiotic Funds, has a...

BMS ditches TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another large bet coming from the Caforio period, terminatin...

Nuvation halts wager inhibitor after considering period 1 data

.After looking at phase 1 record, Nuvation Bio has made a decision to halt focus on its one-time top...

' Medical instinct' led FDA advisors to support Zevra's unusual illness med

.Zevra Therapies' unusual illness drug seems to be to become on the course to permission this loss a...

Pfizer takes $230M attacked after axing neglected DMD gene treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment breakdown has gone a $230 thousan...

AC Immune finds 'landmark' prospective in Alzheimer's drug data

.After greater than two decades of work with neurodegenerative illness, Swiss biotech air conditione...